BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 26983634)

  • 1. Successful treatment of very late drug-eluting stent thrombosis using bare-metal stent evaluated using intravascular ultrasound and optical frequency domain imaging.
    Matsumoto K; Ehara S; Hasegawa T; Sakaguchi M; Yoshikawa J; Shimada K
    Cardiovasc Interv Ther; 2017 Apr; 32(2):159-164. PubMed ID: 26983634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very late stent thrombosis after sirolimus-eluting stent implantation: evaluation by intravascular ultrasound and optical coherence tomography.
    Mabuchi T; Fujino S; Yamaguchi M; Noji Y; Ichise T; Aoyama T
    Cardiovasc Interv Ther; 2013 Oct; 28(4):388-93. PubMed ID: 23558923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case of Single Coronary With Very Late In-Stent Restenosis of Drug-Eluting Stents After 12 Years.
    Vijayvergiya R; Kumar B; Budhakoty S; Kasinadhuni G; Kanabar K
    J Invasive Cardiol; 2019 Nov; 31(11):E333-E334. PubMed ID: 31671063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fate of incomplete stent apposition with drug-eluting stents: an optical coherence tomography-based natural history study.
    Ozaki Y; Okumura M; Ismail TF; Naruse H; Hattori K; Kan S; Ishikawa M; Kawai T; Takagi Y; Ishii J; Prati F; Serruys PW
    Eur Heart J; 2010 Jun; 31(12):1470-6. PubMed ID: 20363765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis.
    Cook S; Ladich E; Nakazawa G; Eshtehardi P; Neidhart M; Vogel R; Togni M; Wenaweser P; Billinger M; Seiler C; Gay S; Meier B; Pichler WJ; Jüni P; Virmani R; Windecker S
    Circulation; 2009 Aug; 120(5):391-9. PubMed ID: 19620501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravascular ultrasound comparison of sirolimus-eluting stent versus bare metal stent implantation in diseased saphenous vein grafts (from the RRISC [Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent] trial).
    Agostoni P; Vermeersch P; Semeraro O; Verheye S; Van Langenhove G; Van den Heuvel P; Convens C; Van den Branden F; Bruining N
    Am J Cardiol; 2007 Jul; 100(1):52-8. PubMed ID: 17599440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difference in vascular response between sirolimus-eluting- and everolimus-eluting stents in ostial left circumflex artery after unprotected left main as observed by optical coherence tomography.
    Fujino Y; Attizzani GF; Tahara S; Naganuma T; Takagi K; Yabushita H; Wang W; Tanaka K; Matsumoto T; Kawamoto H; Yamada Y; Amano S; Watanabe Y; Warisawa T; Sato T; Mitomo S; Kurita N; Ishiguro H; Hozawa K; Tsukahara T; Motosuke M; Bezerra HG; Nakamura S; Nakamura S
    Int J Cardiol; 2017 Mar; 230():284-292. PubMed ID: 28065691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline and 9 months IVUS analysis of the bifurcation-dedicated biolimus A9-eluting Axxess stent system: the DIVERGE IVUS substudy.
    Buysschaert I; Sanidas E; Hasegawa T; Koo BK; Honda Y; Fitzgerald PJ; Verheye S
    Catheter Cardiovasc Interv; 2014 Dec; 84(7):1062-70. PubMed ID: 24478226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical coherence tomography findings in lesions after sirolimus-eluting stent implantation with peri-stent contrast staining.
    Tada T; Kadota K; Hosogi S; Kubo S; Ozaki M; Yoshino M; Miyake K; Eguchi H; Ohashi N; Hayakawa Y; Saito N; Otsuru S; Hasegawa D; Shigemoto Y; Habara S; Imai M; Tanaka H; Fuku Y; Oka N; Kato H; Yamamoto H; Fujii S; Goto T; Mitsudo K
    Circ Cardiovasc Interv; 2012 Oct; 5(5):649-56. PubMed ID: 23011265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravascular ultrasound-guided drug-eluting stent implantation.
    Kadohira T; Kobayashi Y
    Cardiovasc Interv Ther; 2017 Jan; 32(1):1-11. PubMed ID: 27822889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optical coherence tomography analysis of the stenting of saphenous vein graft (SOS) Xience V Study: use of the everolimus-eluting stent in saphenous vein graft lesions.
    Papayannis AC; Michael TT; Yangirova D; Abdel-Karim AR; Kohlhaas J; Mahmood A; Addo T; Haagen D; Makke L; Roesle M; Rangan B; Banerjee S; Brilakis ES
    J Invasive Cardiol; 2012 Aug; 24(8):390-4. PubMed ID: 22865309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison of stent strut coverage following angiography- or optical coherence tomography-guided percutaneous coronary intervention.
    Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Rev Esp Cardiol (Engl Ed); 2015 Mar; 68(3):190-7. PubMed ID: 25487222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug-eluting stent: The ANCHOR study.
    Puri R; Otaegui I; Sabaté M; Serra-Peñaranda A; Puigfel M; Perez de Prado A; Nombela-Franco L; de la Torre Hernandez JM; Ortas Nadal R; Iniguez-Romo A; Jiménez G; Fernandez-Vazquez F; Cuellas-Ramon C; Gonzalo N; Alfonso Jiménez Diaz V; Duocastella L; Molina M; Amoros M; Perez I; Barria Perez A; Pelletier Beaumont E; Nicholls SJ; Garcia Del Blanco B; Rodés-Cabau J
    Catheter Cardiovasc Interv; 2018 Feb; 91(3):435-443. PubMed ID: 28707379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of Late-Acquired Incomplete Stent Apposition: A Comparison With First-Generation and Second-Generation Drug-Eluting Stents.
    Waseda K; Ako J; Kume T; Fitzgerald PJ; Honda Y
    J Invasive Cardiol; 2016 Aug; 28(8):323-9. PubMed ID: 26689416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-stent restenosis is inhibited in a bare metal stent implanted distal to a sirolimus-eluting stent to treat a long de novo coronary lesion with small distal vessel diameter.
    Obata JE; Nakamura T; Kitta Y; Saito Y; Sano K; Fujioka D; Kawabata K; Kugiyama K
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):E777-87. PubMed ID: 23378231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of late-acquired stent malapposition of drug eluting stents with second generation permanent and biodegradable polymer coatings-A prospective, randomized comparison using optical coherence tomography.
    Roth C; Gangl C; Dalos D; Delle-Karth G; Neunteufl T; Berger R
    J Interv Cardiol; 2018 Dec; 31(6):780-791. PubMed ID: 30479028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four-Layer Stent Sandwich for Recurrent In-Stent Occlusion of the Right Coronary Artery: "The Four Musketeers" Fighting for Coronary Flow.
    Grodecki K; Debski A; Witkowski A; Opolski MP
    J Invasive Cardiol; 2018 Oct; 30(10):E109-E110. PubMed ID: 30279301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms, pathophysiology, and clinical aspects of incomplete stent apposition.
    Attizzani GF; Capodanno D; Ohno Y; Tamburino C
    J Am Coll Cardiol; 2014 Apr; 63(14):1355-67. PubMed ID: 24530675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.